Vitacost.com, Inc. is an online-retailer of nutritional supplements, and health & wellness products. The Company sells vitamins, minerals, herbs, anti-oxidants, organic body care, personal care, sports nutrition and health foods direct to consumers through its website and its catalogues.
Unfortunately, for all the shareholders, in December 7th Nasdaq halted trading and you’ll find here in the SEC site the explanation.
Giving that infos about this stock were and continue to be very rare, I thought it was useful to report what Baron reported in its Q4 2010 report. BAMCO, Inc (Baron Capital Group Inc.) is the second largest shareholder and, moreover, having been known for their deep understanding and their long term approach to investing, I suppose their view is quite important.
“(...) In early December, Vitacost announced that it was engaged in an internal review of documentation relating to its stock options and share issuance, and that until the review was completed, it would be unable to file its financial statements. NASDAQ halted trading in Vitacost’s stock, in light of these events, our Fair Valuation Committee has valued the stock down 35% from its last trade. The company’s internal review relates solely to its share count and stock compensation expense, and does not involve the company’s revenues, cash flow or business fundamentals. We remain optimistic about the company’s market opportunity and believe the shares are an attractive investment at the Fair Valuation Committee price levels (...)”.
Following is the list of insider transaction after the date of IPO (9/23/09).
Shares offered: 11.00M, Share Price: $ 12.00, Lock-up Expiration Date: 3/22/2010
Unfortunately, for all the shareholders, in December 7th Nasdaq halted trading and you’ll find here in the SEC site the explanation.
Giving that infos about this stock were and continue to be very rare, I thought it was useful to report what Baron reported in its Q4 2010 report. BAMCO, Inc (Baron Capital Group Inc.) is the second largest shareholder and, moreover, having been known for their deep understanding and their long term approach to investing, I suppose their view is quite important.
“(...) In early December, Vitacost announced that it was engaged in an internal review of documentation relating to its stock options and share issuance, and that until the review was completed, it would be unable to file its financial statements. NASDAQ halted trading in Vitacost’s stock, in light of these events, our Fair Valuation Committee has valued the stock down 35% from its last trade. The company’s internal review relates solely to its share count and stock compensation expense, and does not involve the company’s revenues, cash flow or business fundamentals. We remain optimistic about the company’s market opportunity and believe the shares are an attractive investment at the Fair Valuation Committee price levels (...)”.
Following is the list of insider transaction after the date of IPO (9/23/09).
Shares offered: 11.00M, Share Price: $ 12.00, Lock-up Expiration Date: 3/22/2010
Name | Relation | Definition | Shares | Price | Date |
KERKER IRA P | Officer | Exercise or Conv of derivat | 25,804 | 0 | 9/23/2009 |
LAMBERT SONYA | Officer | Exercise or Conv of derivat | 34,194 | 0 | 9/23/2009 |
SMITH RICHARD P | Officer | Exercise or Conv of derivat | 53,831 | 0 | 9/23/2009 |
TRAPP ROBERT G | Director | Open Market Sale | -132,164 | 12 | 9/24/2009 |
GORSEK WAYNE | 10% Owner | Open Market Sale | -2.35MLN | 12 | 9/24/2009 |
LAMBERT SONYA | Officer | Open Market Sale | -34,194 | 12 | 9/24/2009 |
SMITH RICHARD P | Officer | Open Market Sale | -53,831 | 12 | 9/24/2009 |
JOSEPHS ALLEN S | Director | Open Market Sale | -129,234 | 12 | 9/24/2009 |
JOSEPHS ALLEN S | Director | Open Market Sale | -129,234 | 12 | 9/24/2009 |
PABST LAWRENCE | Director | Open Market Sale | -48,772 | 12 | 9/24/2009 |
PABST LAWRENCE | Director | Open Market Sale | -40,000 | 12 | 9/24/2009 |
PABST LAWRENCE | Director | Open Market Sale | -40,000 | 12 | 9/24/2009 |
KERKER IRA P | Officer | Open Market Sale | -89,804 | 12 | 9/24/2009 |
ILFELD DAVID N | Director | Open Market Purchase | 35,000 | 7.3 | 11/20/2009 |
JOSEPHS ALLEN S | Director | Gift disposition | -180,000 | 0 | 03/04/2010 |
JOSEPHS ALLEN S | Director | Gift acquisition | 180,000 | 0 | 03/04/2010 |
PABST LAWRENCE | Director | Exercise or Conv of derivat | 26,000 | 0.156 | 3/16/2010 |
PABST LAWRENCE | Director | Open Market Sale | -26,000 | 11.99 | 3/16/2010 |